Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Funding for grants on COVID-19 societal impact, outcomes or impact of treatment.
Característiques principals
The following areas of research will be considered in-scope:
a. Societal impact of COVID-19 (Understand the psychological impact, impact on working behaviors, social determinants of health, child development, education, access to healthcare, healthcare resource utilization, direct and indirect costs and impact on QoL)
b. Key populations at high-risk of severe COVID-19 outcomes (Further understand impact of COVID-19 in high-risk population groups, especially in immunocompromised and elderly patients and in patients with multiple co-morbidities).
c. Long term outcomes of COVID-19 (Studies assessing long-term or secondary consequences of the disease, including impact of reinfection and effects of different variants (includes but not exclusive to Long COVID/ post-acute sequelae of SARS CoV-2 infection (PASC)))
d. Treatment of mild-to-moderate COVID-19 in vaccinated and or seropositive patients with nirmatrelvir/ritonavir
e. Impact of treatment for mild-to-moderate COVID-19 with nirmatrelvir/ritonavir on viral load, infectivity and/or transmission and/or viral rebound and/or symptom resolution
f. Regarding use of nirmatrelvir/ritonavir and showing outcomes: prescription behaviors (reason for non-prescription), patient refusal reasons, access and adherence to treatment

Applicants are encouraged to collaborate across departments where appropriate (e.g. education, social services, health etc) and there will be interest in seeing multi-country applications to allow for comparisons between countries on certain areas of interest.
Requests for drug will be accepted. Commercial supply will be available only if approved in your country, not placebo matched drug.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
Marta López: mlopez4@imim.es Ext.: 1576
Carol Barnwell: cbarnwell@imim.es Ext.1670
Convocatòria (URL)
https://click.icptrack.com/icp/relay.php?r=45645091&msgid=245809&act=1C77&c=1552564&pid=885727&destination=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2F2022-10%2FGMG_2022-HBU-G_COVID-19ASPIRE.pdf%3FLQzw7wjc5YNiEoc5J_7Z9El2UEUYaq6D%3D&cf=13590&v=472ee0692bce6da7ad9974ca1d63b5a6732939d5b4be2abf40402236dd24f71f
Requisits
  • Only organizations are eligible to receive grants, not individuals or medical practice groups.
  • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, Psychology or Social Work.
  • Applicant must be affiliated with a host institution.
    • Dotació
    Up to $200,000. Requests for drugs will be accepted.
    Documentació
    Proposals should be submitted at: www.cybergrants.com/pfizer/loi
    AVÍS IMPORTANT
    Letter of Intent (LOI) due date: November 17, 2022
    Full Proposal Deadline: March 31, 2023
    Only accepted LOIs will be invited to submit full proposals

    Arxius

    Arxiu
    GMG_2022-HBU-G_COVID-19ASPIRE.pdf